Showing results (161-170 of 226) with videos related to

Sort By:
Pageof 23
Journal of Gastrointestinal Oncology|June 11, 2016
Acute myeloid leukemia masquerading as hepatocellular carcinomaGhaith F Abu-Zeinah, Paul Weisman, Karuna Ganesh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2010
Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patientsThomas Winder, Wu Zhang, Dongyun Yang, et al.
RNA (New York, N.Y.)|May 19, 2019
A piggyBac-based toolkit for inducible genome editing in mammalian cellsMegan D Schertzer, Eliza Thulson, Keean C A Braceros, et al.
The Journal of Bone and Joint Surgery. American Volume|January 26, 2021
Partial Distal Biceps Avulsion Results in a Significant Loss of Supination ForceYoshiaki Tomizuka, Christopher C Schmidt, Anthony J Davidson, et al.
Molecular Biology of the Cell|February 2, 2022
Quantification of microtubule stutters: dynamic instability behaviors that are strongly associated with catastropheShant M Mahserejian, Jared P Scripture, Ava J Mauro, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Ectopically expressed Airn lncRNA deposits Polycomb with a potency that rivals XistJackson B Trotman, Aki K Braceros, Steven R Bischoff, et al.
Leukemia & Lymphoma|June 23, 2025
Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study - SIMPLICITYMichael J Mauro, Rüdiger Hehlmann, Loretta A Williams, et al.
Leukemia & Lymphoma|March 27, 2019
Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysisJesus G Berdeja, Michael C Heinrich, Shaker R Dakhil, et al.
British Journal of Cancer|January 6, 2011
Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancerJ B Baker, D Dutta, D Watson, et al.
Cancer Research|July 9, 2009
Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in miceDavid Surguladze, Dhanvanthri Deevi, Nidia Claros, et al.
Pageof 23